Avior Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-79	Closed	-$5.77K	–	3068
2024 Q1	$5.77K	Buy	+79	New	+$5.77K	﹤0.01%	2040
2023 Q3	–	Sell	-40	Closed	-$2.88K	–	1651
2023 Q2	$2.88K	Hold	40	–	–	﹤0.01%	1311
2023 Q1	$2.94K	Buy	+40	New	+$2.94K	﹤0.01%	1343